SCHEMBL484677

SCHEMBL484677

O=C(O)N1CCC2(CCN(c3ccc(Cl)cc3)CC2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 4/20 0.50
HSD11B1 P28845 2/20 0.50
ALDH1A1 P00352 6/20 0.49
CYP2C19 P33261 6/20 0.49
MAPK1 P28482 4/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
ALOX12 P18054 1/20 0.49
LMNA P02545 2/20 0.49
CYP3A4 P08684 6/20 0.48
HIF1A Q16665 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
AKR1C3 P42330 3/20 0.48
HTT P42858 1/20 0.48
ITGB3 P05106 2/20 0.47
ITGA2B P08514 2/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484578 0.85 USP2 (0.50) USP2HSD11B1ALDH1A1CYP2C19MAPK1
SCHEMBL640636 0.82 ITGB3 (0.67) ALDH1A1CYP2C19MAPK1HSD17B10CYP2C9
SCHEMBL485114 0.81 AR (0.47) USP2ALDH1A1CYP2C19MAPK1HPGD
SCHEMBL484535 0.81 CYP3A4 (0.55) USP2ALDH1A1CYP2C19MAPK1HPGD
SCHEMBL485229 0.81 CYP3A4 (0.63) USP2ALDH1A1CYP2C19MAPK1HPGD
SCHEMBL21963851 0.80 KDM4E (0.52) USP2ALDH1A1CYP2C19MAPK1HPGD
SCHEMBL484886 0.80 CYP11B2 (0.55) USP2ALDH1A1CYP2C19MAPK1HSD17B10
SCHEMBL23439910 0.80 CYP3A4 (0.67) USP2ALDH1A1CYP2C19MAPK1HPGD
SCHEMBL632099 0.79 LMNA (0.68) ALDH1A1HPGDLMNASMN1; SMN2AKR1C3
SCHEMBL21855247 0.78 CYP3A4 (0.53) USP2ALDH1A1CYP2C19MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN USP2 4864/4885HSD11B1 1789/4885ALDH1A1 2086/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN USP2 4864/4885HSD11B1 1789/4885ALDH1A1 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.